Xibrofen Ophthalmic Solution 0.09%
Xibrofen Ophthalmic Solution 0.09% Uses, Dosage, Side Effects, Food Interaction and all others data.
| Trade Name | Xibrofen Ophthalmic Solution 0.09% |
| Generic | Bromfenac Sodium |
| Weight | 0.09% |
| Type | Ophthalmic Solution |
| Therapeutic Class | Ophthalmic Non-Steroid drugs |
| Manufacturer | Incepta Pharmaceuticals Ltd. |
| Available Country | Bangladesh |
| Last Updated: | October 19, 2023 at 6:27 am |
Uses
Bromfenac is indicated for the treatment of postoperative inflammation and the reduction of ocular pain in patients who have undergone cataract extractionDosage
Xibrofen Ophthalmic Solution 0.09% dosage
Adults: 1 drop to the problem eye 2 times a day; treatment should start 24 hours after surgery and should continue for 2 weeksChildren: Use and dose must be determined by the doctor.Pediatric Use: Safety and efficacy in pediatric patients below the age of 18 have not been established yet.Side Effects
The most commonly reported adverse reactions following use of Bromfenac after cataract surgery include: abnormal sensation in eye, conjunctival hyperemia, eye irritation (including burning/stinging), eye pain, eye pruritus, eye redness, headache and iritis. These events were reported in 2-7% of patientsPrecaution
All topical NSAIDs may slow or delay healing. Topical corticosteroids are also known to slow or delay healing. Concomitant use of topical NSAIDs and topical steroids may increase the potential for healing problems. It is recommended that Bromfenac ophthalmic solution be used with caution in patients with known bleeding tendencies or who are receiving other medications which may prolong bleeding time. Bromfenac ophthalmic solution should not be administered while wearing contact lenses.Bromfenac ophthalmic solution contains Sodium Sulfite, a compound that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Therefore, caution should be used when treating individuals who have previously exhibited sensitivities to these drugs.Pregnancy & Breastfeeding use
Pregnancy Category C. This drug should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution should be exercised when Bromfenac ophthalmic solution is administered to a nursing mother.Contraindication
Bromfenac ophthalmic solution is contraindicated in patients with known hypersensitivity to any ingredients of the formulation.Storage Condition
Keep out of the reach of children. Store in a cool, dry place, away from heat and direct light. Do not use more than 4 weeks after opening.Innovators Monograph
You find simplified version here Xibrofen Ophthalmic Solution 0.09%
